This is the authors' abstract. We don't add key points for this paper.
Multiple myeloma, a plasma-cell neoplasm characterized by skeletal destruction, renal failure, anemia, and hypercalcemia, remains incurable. However, recent advances in its treatment, in particular, the use of thalidomide and such new drugs as bortezomib and CC-5013, are promising. This article discusses current therapy for multiple myeloma.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kyle et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: